Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7.8M

Overview

G-CON is a pioneering leader in the design and manufacturing of prefabricated, modular cleanrooms, primarily serving the life sciences sector. The company's proprietary POD® cleanroom technology enables clients to build and scale GMP-compliant facilities with greater speed, cost certainty, and flexibility compared to traditional stick-built construction. With manufacturing sites in the US and Europe, G-CON addresses the urgent need for rapid, scalable infrastructure in fast-growing fields like cell and gene therapy. Its business model is centered on providing a critical service—manufacturing the controlled environments essential for producing advanced therapeutics.

Medical Devices

Technology Platform

Proprietary PODular cleanroom platform featuring prefabricated, modular cleanroom units (PODs) and components, manufactured off-site in a controlled factory environment for rapid deployment, scalability, and guaranteed compliance (cGMP, ISO).

Funding History

2
Total raised:$7.8M
Series A$5.7M
Seed$2.1M

Opportunities

Explosive growth in cell and gene therapy and biopharmaceuticals drives demand for rapid, flexible, and capital-efficient GMP manufacturing infrastructure.
Additionally, government-led initiatives to reshore semiconductor manufacturing create a significant new market for high-grade cleanroom solutions.
The industry-wide shift towards sustainable construction practices aligns perfectly with G-CON's efficient, factory-built model.

Risk Factors

Revenue is tied to the capital expenditure cycles of the biopharma and tech sectors, which can be volatile.
The company faces increasing competition from both traditional construction firms and new modular specialists.
Its model is also exposed to execution risks, including global supply chain disruptions and on-site integration challenges at client facilities.

Competitive Landscape

G-CON competes in the modular cleanroom space against other prefabricated cleanroom manufacturers and traditional design-build engineering and construction firms serving the life sciences sector. Key differentiators are its pioneering POD platform, extensive portfolio, focus on speed and certainty, and deep specialization in high-growth areas like cell and gene therapy. Competition is based on technology, speed, cost, reliability, and regulatory expertise.